{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-102812","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2023-09-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.938460+00:00","generated_at":"2026-06-10T10:50:30.291251+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Elutia raises $10.5M in PIPE with up to $26.2M from warrants; plus divestiture >$60M total cash","bullets":["Initial gross proceeds ~$10.5M from sale of 7.36M shares/pre-funded warrants and 11.03M common warrants.","Full exercise of warrants would add $15.8M, bringing total PIPE proceeds to $26.2M.","Combined with Orthobiologics divestiture (announced Sep 18), total cash added >$60M.","Warrants exercisable at $1.4275 until 30 trading days post-FDA clearance of CanGarooRM or 5 years.","Investors include existing HighCape Capital, new Nantahala Capital, and a life-sciences fund."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-102812","json":"https://secwatch.observer/filing/0001104659-23-102812.json","markdown":"https://secwatch.observer/filing/0001104659-23-102812.md","text":"https://secwatch.observer/filing/0001104659-23-102812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/0001104659-23-102812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/tm2326577d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T10:50:30.291251+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c8a7dde1adc34f3f23fbe1ce5c86a35549a270a2","claim":"ELUTIA INC. entered into Securities Purchase Agreement with purchasers named therein valued at aggregate gross proceeds of approximately $10.5 million (effective 2023-09-18).","evidence_excerpt":"On September 18, 2023, Elutia Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchasers named therein (the “Investors”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/0001104659-23-102812-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"purchasers named therein"},{"label":"Value","value":"aggregate gross proceeds of approximately $10.5 million"},{"label":"Effective","value":"2023-09-18"}],"fact_type":"material_agreement"},{"claim_id":"fe3ea452b7c01a5d825fb9a9ef7d893b0b98dc8a","claim":"ELUTIA INC. entered into Registration Rights Agreement with purchasers named therein valued at Company agreed to prepare and file a registration statement within 60 days after closing (effective 2023-09-21).","evidence_excerpt":"On September 21, 2023, in connection with the closing of the Offering, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investors.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708527/000110465923102812/0001104659-23-102812-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"purchasers named therein"},{"label":"Value","value":"Company agreed to prepare and file a registration statement within 60 days after closing"},{"label":"Effective","value":"2023-09-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}